|
Jim Langevin on Stem Cell Research
One of my top priorities as a Member of Congress has been to expand the federal funding of embryonic stem cell research. I joined a group of my colleagues in introducing H.R. 810, the Stem Cell Research Enhancement Act. On May 24, 2005, the House of Representatives passed H.R. 810, which would expand the existing federal policy on embryonic stem cell research by lifting the August 9, 2001, cutoff. Under this legislation, all other parameters established by the President would remain in place. Research would be limited to those lines derived from excess embryos, as a result of the in vitro fertilization process. Further, the bill clearly states that informed consent from the donors must be obtained and that the purchase and sale of embryos is prohibited. Our government must support and oversee further research into this promising field that could offer countless people new hope. I have pledged to work tirelessly as voice for the millions of Americans suffering from diseases and chronic conditions for which this research holds the promise of treatments or cures. We simply must provide our nation's scientists with the tools they need to realize the full potential of this historic research. This support represents the most noble activity in which our government can engage: the protection, promotion, and, indeed, affirmation of the lives of our most vulnerable citizens. |
Select An Issue
|